CellaVision AB (publ) (CEVI.ST)
Makes machines that automatically analyze blood cells under microscopes for labs.
146.00+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-14.4%
The outlook
CEVI.ST trades near the lower end of its 52-week range with analysts broadly positive, averaging a Strong Buy rating. The average price target sits roughly 21% above the current level, though the stock is showing mixed momentum against its moving averages. At a trailing P/E of 26.9, the valuation reflects growth expectations amid analyst optimism.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 4 analysts
Price trendMixed vs its moving averages
52-week range38% of the way from its 52-week low to high
Price targetAvg target +21% vs current price
Analyst price target
~12-month · 4 analysts176.75average target+21.1% vs now
Now 146.00
Low 160.00High 187.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$3.48B
52-wk high
192.20
52-wk low
117.60
50-day avg
133.76
200-day avg
148.15
Trailing P/E
26.9